Genome Medical will use the proceeds of its Series A-1 financing to expand its nationwide footprint, as well as to invest in its telegenomics platform.
The conference held last week in Bethesda, Md., looked at how the public was receiving information about their own genetics, as well as advances in the field via blogs and the mainstream media.
